Mereo BioPharma announces Positive Top-Line Efficacy and Safety Data from “ASTRAEUS” Phase 2 Trial of Alvelestat in Alpha-1 Antitrypsin Deficiencyassociated Emphysema

Conference Call and Webcast
Mereo BioPharma will hold a conference call today, May 9, at 10:30am EDT. To participate by telephone, please dial US (toll free): (866) 374-5140 or international: (404) 400-0571. The conference ID number is 50222760. To view the slideshow please use the live webcast at https://wsw.com/webcast/cc/mph.l3/1480428.An archived replay of the webcast will be available on the Company’s website for two week following the live presentation.